283 related articles for article (PubMed ID: 8943365)
1. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.
Devergne O; Hatzivassiliou E; Izumi KM; Kaye KM; Kleijnen MF; Kieff E; Mosialos G
Mol Cell Biol; 1996 Dec; 16(12):7098-108. PubMed ID: 8943365
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
[TBL] [Abstract][Full Text] [Related]
3. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.
Izumi KM; Cahir McFarland ED; Riley EA; Rizzo D; Chen Y; Kieff E
J Virol; 1999 Dec; 73(12):9908-16. PubMed ID: 10559303
[TBL] [Abstract][Full Text] [Related]
4. Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression.
Devergne O; Cahir McFarland ED; Mosialos G; Izumi KM; Ware CF; Kieff E
J Virol; 1998 Oct; 72(10):7900-8. PubMed ID: 9733827
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein.
Kaye KM; Devergne O; Harada JN; Izumi KM; Yalamanchili R; Kieff E; Mosialos G
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):11085-90. PubMed ID: 8855313
[TBL] [Abstract][Full Text] [Related]
6. Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression.
Miller WE; Cheshire JL; Raab-Traub N
Mol Cell Biol; 1998 May; 18(5):2835-44. PubMed ID: 9566902
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
[TBL] [Abstract][Full Text] [Related]
8. TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.
Greenfeld H; Takasaki K; Walsh MJ; Ersing I; Bernhardt K; Ma Y; Fu B; Ashbaugh CW; Cabo J; Mollo SB; Zhou H; Li S; Gewurz BE
PLoS Pathog; 2015 May; 11(5):e1004890. PubMed ID: 25996949
[TBL] [Abstract][Full Text] [Related]
9. TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.
Eliopoulos AG; Waites ER; Blake SM; Davies C; Murray P; Young LS
J Virol; 2003 Jan; 77(2):1316-28. PubMed ID: 12502848
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation.
Miller WE; Mosialos G; Kieff E; Raab-Traub N
J Virol; 1997 Jan; 71(1):586-94. PubMed ID: 8985387
[TBL] [Abstract][Full Text] [Related]
11. LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3.
Wu S; Xie P; Welsh K; Li C; Ni CZ; Zhu X; Reed JC; Satterthwait AC; Bishop GA; Ely KR
J Biol Chem; 2005 Sep; 280(39):33620-6. PubMed ID: 16009714
[TBL] [Abstract][Full Text] [Related]
12. The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex.
Fries KL; Miller WE; Raab-Traub N
Virology; 1999 Nov; 264(1):159-66. PubMed ID: 10544141
[TBL] [Abstract][Full Text] [Related]
13. Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation.
Song YJ; Kang MS
Virus Genes; 2010 Oct; 41(2):174-80. PubMed ID: 20585848
[TBL] [Abstract][Full Text] [Related]
14. Unique signaling properties of CTAR1 in LMP1-mediated transformation.
Mainou BA; Everly DN; Raab-Traub N
J Virol; 2007 Sep; 81(18):9680-92. PubMed ID: 17626074
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.
Luftig M; Yasui T; Soni V; Kang MS; Jacobson N; Cahir-McFarland E; Seed B; Kieff E
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):141-6. PubMed ID: 14691250
[TBL] [Abstract][Full Text] [Related]
16. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma.
Siegler G; Kremmer E; Gonnella R; Niedobitek G
Mol Pathol; 2003 Jun; 56(3):156-61. PubMed ID: 12782762
[TBL] [Abstract][Full Text] [Related]
18. The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation.
Izumi KM; Cahir McFarland ED; Ting AT; Riley EA; Seed B; Kieff ED
Mol Cell Biol; 1999 Aug; 19(8):5759-67. PubMed ID: 10409763
[TBL] [Abstract][Full Text] [Related]
19. Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1.
Graham JP; Moore CR; Bishop GA
J Immunol; 2009 Sep; 183(5):2966-73. PubMed ID: 19667091
[TBL] [Abstract][Full Text] [Related]
20. Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling.
Xie P; Hostager BS; Munroe ME; Moore CR; Bishop GA
J Immunol; 2006 May; 176(9):5388-400. PubMed ID: 16622006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
